To test the effects of the MCL1 inhibitor S64315 on the viability of human MDSCs, we conducted in vitro tests with MDSCs isolated from 5 healthy human subjects and an acute promyelocytic leukemia cell line HL-60 (an immature MDSC model) (Fig. 4A). This evidence concerns the gene MCL1 and acute promyelocytic leukemia.